IOVA → $75.00 by Nov 21, 2027.

I am writing this on my phone. So forgive me for any typos or formatting mistakes. What IOVA does? Iovance Biotherapeutics is the first company to get an FDA approval for a cell therapy that works in solid tumors. (Roughly over 90%, remaining 10% being Blood) Their product, Amtagvi (lifileucel), is a one-time TIL therapy (tumor-infiltrating lymphocytes). Doctors take T cells from the tumor, Iovance expands them into billions, and those cells get infused back into the patient. Very intuitive, …